Announcements Trials

Browse Landscape

Phase

Phase 2 16 Phase 3 8 Phase 1/2 5 Phase 1 4 Phase 2/3 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 5 Lymphoma 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Large B-Cell, Diffuse 4 Leukemia 3 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Sezary Syndrome 1 Neoplasms 1 Neoplasm Metastasis 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Large Granular Lymphocytic 1 Burkitt Lymphoma 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 4 gamma-Globulins 3 Standard of Care 3 Oxaliplatin 3 Melatonin 3 Gemcitabine 3 Fluorouracil 3 Drug Therapy 3 Ciprofloxacin 3 Capecitabine 3 pertuzumab 2 entrectinib 2 cobimetinib 2 capmatinib 2 atezolizumab 2 alectinib 2 Water 2 Vemurafenib 2 Trastuzumab 2 Sirolimus 2 Saline Solution 2 Pemetrexed 2 Methylphenidate 2 Lidocaine 2 Leucovorin 2 Immunoglobulins, Intravenous 2 Docetaxel 2 Dexmedetomidine 2 Cisplatin 2 Carboplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Neoplasms × Prednisone × Clear all

NCT03348670 2025-08-17

Drugs-SNPs

Medicine Invention Design, Inc

Phase 2/3 Active not recruiting

Neoplasms, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡